600196 復星醫藥
按盤價 
22.890 +0.030 (+0.131%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.532 | 7.022 | 5.960 | 5.287 | 8.906 |
| 總資產報酬率 ROA (%) | 1.403 | 2.838 | 2.399 | 2.163 | 3.722 |
| 投入資產回報率 ROIC (%) | 1.788 | 3.618 | 3.056 | 2.758 | 4.844 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.671 | 50.074 | 47.974 | 47.837 | 47.284 |
| 營業利潤率 (%) | 12.797 | 12.550 | 10.337 | 7.989 | 10.595 |
| 息稅前利潤/營業總收入 (%) | 15.251 | 15.039 | 12.856 | 10.263 | 11.881 |
| 淨利潤/營業總收入 (%) | 10.512 | 10.196 | 8.553 | 6.993 | 8.981 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 29.357 | 30.796 | 40.047 | 3.537 | 56.954 |
| 價值變動淨收益/利潤總額(%) | 68.313 | 67.322 | 47.698 | 94.181 | 41.087 |
| 營業外收支淨額/利潤總額(%) | -1.135 | -2.276 | -1.819 | -1.315 | -1.799 | 償債能力分析 |
| 流動比率 (X) | 0.902 | 0.929 | 0.921 | 1.001 | 1.059 |
| 速動比率 (X) | 0.747 | 0.757 | 0.727 | 0.778 | 0.853 |
| 資產負債率 (%) | 49.452 | 48.490 | 48.975 | 50.104 | 49.508 |
| 帶息債務/全部投入資本 (%) | 39.595 | 38.012 | 37.960 | 38.273 | 37.447 |
| 股東權益/帶息債務 (%) | 125.695 | 135.483 | 135.770 | 133.295 | 142.559 |
| 股東權益/負債合計 (%) | 78.566 | 83.729 | 82.155 | 80.355 | 84.031 |
| 利息保障倍數 (X) | 5.871 | 5.432 | 4.754 | 4.317 | 8.066 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.671 | 74.817 | 68.357 | 66.226 | 55.771 |
| 存貨周轉天數 (天) | 106.912 | 116.923 | 124.656 | 120.194 | 95.983 |
| 備註： | 即時報價更新時間為 27/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
